Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review

Signs of rapid proliferation in the pathologic specimen of both cases were recorded. During follow-up both cases developed recurrent tumor within a month after first three cycles first-line temozolomide CT.